Accelerate Diagnostics, Inc. (AXDX): Price and Financial Metrics


Accelerate Diagnostics, Inc. (AXDX): $0.75

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AXDX POWR Grades

  • Growth is the dimension where AXDX ranks best; there it ranks ahead of 76.63% of US stocks.
  • The strongest trend for AXDX is in Growth, which has been heading down over the past 177 days.
  • AXDX's current lowest rank is in the Momentum metric (where it is better than 1.12% of US stocks).

AXDX Stock Summary

  • ACCELERATE DIAGNOSTICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 4.68% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -1.76 for ACCELERATE DIAGNOSTICS INC; that's greater than it is for just 4.92% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AXDX comes in at -70.07% -- higher than that of merely 8.07% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ACCELERATE DIAGNOSTICS INC are BFLY, VIVE, BLZE, OCX, and VRAR.
  • Visit AXDX's SEC page to see the company's official filings. To visit the company's web site, go to acceleratediagnostics.com.

AXDX Valuation Summary

  • In comparison to the median Healthcare stock, AXDX's price/earnings ratio is 104.7% lower, now standing at -1.1.
  • Over the past 243 months, AXDX's EV/EBIT ratio has gone up 4.7.

Below are key valuation metrics over time for AXDX.

Stock Date P/S P/B P/E EV/EBIT
AXDX 2022-12-02 5.7 -7.6 -1.1 -1.7
AXDX 2022-12-01 6.2 -8.4 -1.2 -1.8
AXDX 2022-11-30 6.6 -8.8 -1.2 -1.9
AXDX 2022-11-29 6.5 -8.7 -1.2 -1.9
AXDX 2022-11-28 6.6 -8.9 -1.2 -1.9
AXDX 2022-11-25 7.3 -9.7 -1.4 -2.0

AXDX Growth Metrics

    Its 3 year net income to common stockholders growth rate is now at 24.19%.
  • The 5 year net cashflow from operations growth rate now stands at -17.75%.
  • The 4 year price growth rate now stands at -58.78%.
Over the past 33 months, AXDX's revenue has gone up $3,825,000.

The table below shows AXDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 13.122 -51.125 -70.496
2022-06-30 13.284 -50 -63.777
2022-03-31 12.221 -46.554 -67.648
2021-12-31 11.782 -47.323 -77.702
2021-09-30 11.547 -45.719 -73.811
2021-06-30 12.013 -45.927 -83.582

AXDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AXDX has a Quality Grade of D, ranking ahead of 23.75% of graded US stocks.
  • AXDX's asset turnover comes in at 0.125 -- ranking 68th of 75 Measuring and Control Equipment stocks.
  • AATC, TMO, and BMI are the stocks whose asset turnover ratios are most correlated with AXDX.

The table below shows AXDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.125 0.366 -0.333
2021-03-31 0.112 0.379 -0.320
2020-12-31 0.103 0.399 -0.302
2020-09-30 0.097 0.418 -0.316
2020-06-30 0.079 0.458 -0.343
2020-03-31 0.071 0.467 -0.358

AXDX Price Target

For more insight on analysts targets of AXDX, see our AXDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.00 Average Broker Recommendation 1.7 (Moderate Buy)

AXDX Stock Price Chart Interactive Chart >

Price chart for AXDX

AXDX Price/Volume Stats

Current price $0.75 52-week high $5.59
Prev. close $0.75 52-week low $0.50
Day low $0.74 Volume 295,200
Day high $0.79 Avg. volume 722,181
50-day MA $1.30 Dividend yield N/A
200-day MA $1.38 Market Cap 61.17M

Accelerate Diagnostics, Inc. (AXDX) Company Bio


Accelerate Diagnostics is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company was founded in 1982 and is based in Tucson, Arizona.


AXDX Latest News Stream


Event/Time News Detail
Loading, please wait...

AXDX Latest Social Stream


Loading social stream, please wait...

View Full AXDX Social Stream

Latest AXDX News From Around the Web

Below are the latest news stories about ACCELERATE DIAGNOSTICS INC that investors may wish to consider to help them evaluate AXDX as an investment opportunity.

Accelerate Diagnostics Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag

Accelerate Diagnostics ( NASDAQ:AXDX ) Third Quarter 2022 Results Key Financial Results Revenue: US$2.96m (down 5.2...

Yahoo | November 16, 2022

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter for the period ended September 30, 2022.

Yahoo | November 14, 2022

Why Accelerate Diagnostics Shares Are Plummeting Today?

Accelerate Diagnostics Inc (NASDAQ: AXDX) said that according to recent discussions, the FDA has clarified that the company must obtain a 510(k) clearance to continue marketing and distributing the Accelerate Arc Products in the U.S. Accelerate Arc Products include Accelerate Arc system and related BC Kit. The company had been listing the Accelerate Arc Products as a Class I device exempt from 510(k) clearance requirements. The company intends to continue fully cooperating with the FDA, promptly

Yahoo | October 24, 2022

Accelerate Diagnostics scheduled call to review 2022 third quarter results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, November 14, 2022, at 4:30 p.m. Eastern Time to review 2022 third quarter results.

Yahoo | October 24, 2022

Silk Road Medical (SILK) Stock Jumps 6.7%: Will It Continue to Soar?

Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | October 19, 2022

Read More 'AXDX' Stories Here

AXDX Price Returns

1-mo -40.00%
3-mo -52.53%
6-mo 17.28%
1-year -84.28%
3-year -95.28%
5-year -97.34%
YTD -85.63%
2021 -31.13%
2020 -55.15%
2019 46.96%
2018 -56.11%
2017 26.27%

Continue Researching AXDX

Want to see what other sources are saying about Accelerate Diagnostics Inc's financials and stock price? Try the links below:

Accelerate Diagnostics Inc (AXDX) Stock Price | Nasdaq
Accelerate Diagnostics Inc (AXDX) Stock Quote, History and News - Yahoo Finance
Accelerate Diagnostics Inc (AXDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9089 seconds.